𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial)

✍ Scribed by I. V. Litvinenko; M. M. Odinak; V. I. Mogil’naya; A. Yu. Emelin


Publisher
Springer US
Year
2008
Tongue
English
Weight
139 KB
Volume
38
Category
Article
ISSN
0097-0549

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


What happens when donepezil is suddenly
✍ Thaís S. C. Minett; Alan Thomas; Lucy M. Wilkinson; Sarah L. Daniel; Jonathan Sa 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

## Abstract ## Background This open label study was designed to assess the effects of donepezil treatment, its withdrawal and subsequent recommencement on cognitive functioning, behaviour and parkinsonian symptoms in patients with probable dementia with Lewy bodies (DLB) and with Parkinson's disea

Efficacy and safety of donepezil over 3
✍ A. Burns; S. Gauthier; C. Perdomo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective This 132‐week, open‐label extension study assessed the long‐term efficacy and safety of donepezil in 579 patients with mild to moderate Alzheimer's disease (AD) who had previously participated in a 24‐week double‐blind study of 5 or 10 mg/day donepezil __vs__ placebo. ##

Efficacy and safety of donepezil in pati
✍ Howard Feldman; Serge Gauthier; Jane Hecker; Bruno Vellas; Yikang Xu; John R. Ie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

## Abstract ## Background There have been very limited investigations of cholinesterase inhibitor therapy in more advanced stages of Alzheimer's disease (AD). The efficacy and safety of donepezil were evaluated in __post hoc__ analyses of a subgroup of patients with more severe AD (standardized Mi

Therapeutic efficacy of bilateral prefro
✍ Nataša Dragaševic; Aleksandra Potrebić; Aleksandar Damjanović; Elka Stefanova; V 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Recent studies have suggested that both high- and low-frequency repetitive transcranial magnetic stimulation (rTMS) have antidepressant effects in patients with major depression. We conducted an open study to assess the effects of slow rTMS on mood changes in patients with depression associated with